Clinical trials
Lupus Erythematosus, Systemic trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Active, not recruiting | 12 |
| Terminated | 9 |
| Enrolling by invitation | 3 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Biogen | 3 |
| Eli Lilly and Company | 3 |
| UCB Biopharma SRL | 3 |
| Viatris Innovation GmbH | 3 |
| Anthera Pharmaceuticals | 2 |
| AstraZeneca | 2 |
| EMD Serono | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Genentech, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 49 |
| Autoimmune Diseases | 12 |
| Connective Tissue Diseases | 8 |
| Immune System Diseases | 7 |
| Lupus Erythematosus, Cutaneous | 3 |
| Lupus Erythematosus, Discoid | 3 |
| Lupus Nephritis | 3 |
| Dermatomyositis | 1 |
| Mycobacterium Infections, Nontuberculous | 1 |
| Nephritis | 1 |
Trials
Showing 76 to 49 of 49. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.